the interesting thing is, the chart seems to be leveling

New Post Public Reply Private Reply Replies (1) Message Board
joey68 joey68 #136
207
the interesting thing is, the chart seems to be leveling off.
View My Board Here:
http://investorshangout.com/Joeys-Investment-Board-91611/


Invite Only

There is a VERY HIGH degree of RISK involved in trading and investing. Only invest what you can afford to lose.

Disclaimer:
As used herein, the terms "You" and "Your" shall mean you, individually, the reader, and each other party on whose behalf you may use the contained information at any time.
All references to "My", "I", and “The writer of the above post” shall refer to the creator of the username Joey68.

Do NOT invest unless you are prepared to sustain a total loss of the money you have invested plus any commission or other transaction charges.

There is a very high degree of risk involved in trading and investing. Past results are not indicative of future returns. I assume no responsibility for your trading and investment results. You should NOT rely on the information in the above post to make any decision or take any action.

ALL OF MY STATEMENTS, including but not limited to, POSTS, MESSAGES, PRIVATE MESSAGES, and RESPONSES are OPINION and NOT fact and are for entertainment purposes only. Do your own research and make your own decisions based on your own conclusions.
ALL OF MY STATEMENTS, including but not limited to, POSTS, MESSAGES, PRIVATE MESSAGES, and RESPONSES are NOT advice, and are NOT designed to substitute the expertise and judgment of a professional. It is your responsibility to seek investment advice during all stages of your investments. It is your responsibility to evaluate the accuracy, completeness and usefulness of the information in the above post.
I am NOT a professional.
I do NOT work for you.
My posts are NOT investment advice. I am not paid to post.
There is no correlation between the number of posts I write per day and your assumed success of a company.
It is NOT my responsibility to inform you of my own personal investment decisions.
It is NOT my responsibility to inform you when it is time for you to buy, hold, and/or sell a position.
I have no control over, and am not responsible for the actions of others who copy, store, edit, change, prepare any derivative work of or alter in any way any of the content provided in my posts.
Errors and Omissions expected. The writer of the above post accepts no liability or responsibility for any errors or omissions contained in the above post or contained within this Disclaimer.
The writer of the above post shall NOT accept any liability for the accuracy or completeness of the information contained in the above post, for any reliance placed by any person on the information contained in the above post, or for any damage or loss, however caused, in connection with the use or reliance on any information contained in the above post.
The above post may contain links to websites owned and operated by third parties. These links are provided for informational purposes only and are NOT endorsed by the writer of the above post. The writer of the above post has no control over the contents of any linked website and bears no responsibility for the accuracy, legality, or content of the external site or for that of subsequent links.
YOU ACCESS ALL LINKS ENTIRELY AT YOUR OWN RISK.
The writer of the above post makes no warranties or representations, express or implied about such linked websites, the third parties they are owned and operated by, or the information contained on these websites.
The writer of the above post accepts no liability for any damage or loss, however caused, in connection with the use of or reliance on any information, material, products, or services contained on or accessed through any such linked websites.

There is a VERY HIGH degree of RISK involved in trading and investing. Only invest what you can afford to lose.
Scroll down for more posts ▼

Top 10 Most Recent News Articles

Sirha Lyon® 2027: A New Chapter in Foodservice

Updated Category News Views 162

A Bold Step Forward There's a hearty aroma wafting from Lyon this January, and it's not just from the local gastronomy. Sirha Lyon® is queuing up for its 23rd edition, promising to turn the Foodservice and Hospitality sectors on their heads. Nearly 150,000 square meters of exhibition space packed to the rafters with over 4,300 exhibitors—this ain't your average trade...

Continue Reading
BCG Pinpoints Fatal Ignorance in Critical Mineral Risks

Updated Category News Views 0

Unseen Weakness in Industrial Giants Imagine staring right past a pothole while driving, then wondering why you keep popping your tires. That's where industrial companies find themselves today with critical minerals, according to a new wake-up call from Boston Consulting Group. The giant problem? Firms are blissfully unaware of the mosquitoes in their machines—tiny,...

Continue Reading
Fulcra Unveils DIY Web App Tool for AI Agent Users

Updated Category News Views 87

Fulcra Dynamics Pushes the Boundaries with New Tool There's always that moment when a company nudges the needle, and Fulcra Dynamics seems to have done just that with its latest release. They've unveiled an ingenious tool that promises a shake-up in how we build and use web applications with AI. It's the kind of move that makes you stop and wonder if we're witnessing the...

Continue Reading
Skechers Facing Class Action: Investors Urged to Act

Updated Category News Views 50

Skechers Under Fire: Fraud Allegations Surface Alright, if you've been around the stock block a while, you know these stories can often read like a suspense novel. Plot twist: Skechers U.S.A., Inc. (formerly NYSE: SKX) is now facing some serious accusations. There's a class action lawsuit claiming that some shady dealings went down during the company's $9.4 billion...

Continue Reading
Gildan's Troubling Legal Struggles: Investor Action Alert

Updated Category News Views 76

Gildan's Bumpy Ride: Legal Woes Unfold Well, folks, seems like Gildan Activewear Inc. (NYSE:GIL) is in for a bumpy ride, and not the kind that makes you feel alive, I tell ya. They've been slapped with a class action lawsuit, and the news ain't pretty. Accusations are flying hot about how they've been playing fast and loose with their financials. The Allegations: Channel...

Continue Reading
OncoHost's Research Links TKI Sensitivity to Biology

Updated Category News Views 163

Cracking the Code on TKI Sensitivity When it comes to medicine, sometimes the trickiest part is knowing which button to push—especially in the high-stakes world of metastatic renal cell carcinoma (mRCC). OncoHost just dropped a bombshell at the ESMO 2026 Congress about their new plasma proteomics model that lets us peer into what makes some patients click with Tyrosine...

Continue Reading
Bladex Declares Quarterly Dividend for Q3 2026

Updated Category News Views 61

Bladex's Steady Dividend: What's Under the Hood? Well, well, it looks like Bladex is doing the old dividend dance again. They've just announced a quarterly cash dividend of $0.6875 per share for the third quarter of 2026. It's scheduled for payout on November 24 to those who have their noses in the ledger come November 6—that's your record date, folks. Now, dividends...

Continue Reading
Post University Expands with New Tech and Health Degrees

Updated Category News Views 46

If you're looking to invest in an education with promising payoffs, you might look into what's cooking over at Post University. They've just dropped a bombshell of new programs sure to get some attention from tech heads and health nuts alike, and I can't help but think there's potential brewing here. New Academic Paths Emerge Post University isn't resting on its...

Continue Reading
Nucor's Q3 2026 Earnings: Strong Growth Amid Steel Surge

Updated Category News Views 89

Nucor's Solid Third Quarter Performance Nucor Corporation is flexing its muscles, reporting a robust third quarter for 2026. With net earnings hitting $1.32 billion and a diluted earnings per share of $5.80, the steel giant has shown it can more than hold its ground in a competitive market. Compare that to last quarter's $1.16 billion - we're seeing serious momentum....

Continue Reading
Surgery Partners Buyout: Fair Deal or Insider Jackpot?

Updated Category News Views 66

What's Going On With Surgery Partners? Alright, here's the scoop that shareholders can't ignore—Surgery Partners (NYSE:SGRY) could be heading under the scalpel itself with a proposed buyout by HealthSpan. For those holding onto SGRY stock, this might feel like watching the rerun of a medical drama where the ending ain't clear yet. Shareholders are set to get $23.50 a...

Continue Reading

Top 5 Most Recently Viewed Articles

Ashcroft Capital's Strategic Acquisition of The Avery Community

Updated Category News Views 342

Strategic Moves by Ashcroft Capital for 2025 Ashcroft Capital, a multi-faceted real estate investment firm, is gearing up for an exciting year ahead as it focuses on strategic acquisitions in the multifamily sector. Their latest achievement is the recapitalization of The Avery, a luxurious apartment community renowned for its excellent living standards. The...

Continue Reading
BCE Optimizes Value with Normal Course Issuer Bid Renewal

Updated Category News Views 131

BCE Inc. Announces Renewal of Normal Course Issuer Bid BCE Inc. is proud to share that it has secured approval from the Toronto Stock Exchange (the "TSX") for the renewal of its normal course issuer bid ("NCIB"). This program enables BCE to repurchase up to 10% of the public float of its outstanding First Preferred Shares, which are traded on the TSX. Details of the NCIB...

Continue Reading
Monopar Showcasing Promising Long-Term Data for ALXN1840

Updated Category News Views 246

Monopar's Presentation at the American Neurological Association Meeting Monopar Therapeutics Inc. is excited to share groundbreaking new data regarding the long-term neurological efficacy and safety of its investigational therapy, ALXN1840, targeting Wilson disease, at the upcoming 150th American Neurological Association (ANA) Annual Meeting. Renowned neurologist Dr....

Continue Reading
Legal Actions Surrounding DexCom's Controversial Glucose Devices

Updated Category News Views 267

Legal Action Against DexCom, Inc. Pomerantz LLP has recently announced a significant class action lawsuit against DexCom, Inc. (NASDAQ: DXCM) and some of its officers. This legal action, which has been filed in a U.S. District Court, aims to represent those individuals and entities who purchased DexCom securities within a specified timeline. The lawsuit seeks to recover...

Continue Reading
Red Roof Partners with Canine Companions for a Worthy Cause

Updated Category News Views 105

Red Roof Partners with Canine Companions to Make a Difference Red Roof®, a well-respected name in the lodging industry, is renewing its partnership with Canine Companions to bring a unique initiative called the Room In Your Heart® program to fruition. This program aims not only to offer discounts to travelers but also to support the vital cause of providing trained...

Continue Reading